- Anti Cardiolipin IgG Antibodies (1)
- Anti Cardiolipin IgG Antibodies
- Anti Cardiolipin IgM Antibodies (1)
- Anti Cardiolipin IgM Antibodies
- Beta 2 Glycoprotein IgG & IgM (2)
- Beta 2 Glycoprotein IgG
- Beta 2 Glycoprotein IgM
- Lupus Anticoagulant (4)
- Control Value
- Lupus Anticoagulant
- Patient Value
- Screen Ratio
- Phospholipid IgG & IgM (2)
- Phospholipid IgG
- Phospholipid IgM
Understanding APLA Panel: Assessing Antiphospholipid Antibodies
The Anti Phospholipid Antibody (APLA) Panel is a group of tests designed to detect specific antibodies that target phospholipids, a type of fat found in the cell membranes. These antibodies are associated with a condition known as antiphospholipid syndrome (APS), an autoimmune disorder that can lead to abnormal blood clotting and pregnancy complications.
1. Anti Cardiolipin IgG and IgM Antibodies: These tests measure the presence of IgG and IgM antibodies against cardiolipin, a phospholipid found in cell membranes. Elevated levels of these antibodies can increase the risk of blood clots.
2. Beta 2 Glycoprotein IgG and IgM: This panel includes tests for both IgG and IgM antibodies against beta 2 glycoprotein, a protein that interacts with phospholipids. Abnormal levels of these antibodies may contribute to the development of blood clots.
3. Lupus Anticoagulant: The Lupus Anticoagulant test evaluates the presence of antibodies that interfere with the body’s normal clotting process. Despite its name, the Lupus Anticoagulant is associated with an increased risk of clotting rather than bleeding. The panel provides control values, patient values, and a screen ratio to assess the impact of these antibodies.
4. Phospholipid IgG and IgM: This panel includes tests for both IgG and IgM antibodies against various phospholipids. The presence of these antibodies may lead to an increased risk of clot formation.
Why APLA Panel is Important:
The APLA Panel is crucial for diagnosing antiphospholipid syndrome (APS) and identifying individuals at risk of abnormal blood clotting. APS can lead to serious health complications, including deep vein thrombosis, pulmonary embolism, and recurrent pregnancy loss. Early detection and proper management of APS can significantly reduce the risk of complications.
Take Control of Your Health:
At [Your Clinic/Hospital Name], we are dedicated to providing comprehensive testing for autoimmune disorders. Our APLA Panel helps assess your risk of antiphospholipid syndrome and empowers you to take proactive measures to protect your health. Our experienced team of healthcare professionals ensures accurate and timely results, guiding you towards optimal health outcomes.